# Microvascular Invasion Artificial Intelligence Prediction Via Contrast-enhanced Ultrasound With Explainability

> **NCT06760494** · — · COMPLETED · sponsor: **Chinese PLA General Hospital** · enrollment: 250 (actual)

## Conditions studied

- HCC - Hepatocellular Carcinoma
- Microvascular Invasion (MVI)

## Interventions

- **DIAGNOSTIC_TEST:** the MAPUSE model

## Key facts

- **NCT ID:** NCT06760494
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-01
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-05-30
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2025-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06760494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06760494, "Microvascular Invasion Artificial Intelligence Prediction Via Contrast-enhanced Ultrasound With Explainability". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06760494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*